KTTA Clinical trials Pasithea Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference Published August 28, 2025 at 11:02 AM Pasithea Tx (Nasdaq: KTTA) to present PAS-004 clinical progress at H.C. Wainwright Global Investment Conference on Sept. 10, 2025 in NYC. Find similar articles on Candlesense globenewswire